Abstract
Conclusion
The role of organic calcium antagonists in prevention of atherosclerosis in animals is unsettled and appears to involve interaction with variables not yet defined. Interpretation should therefore be made with caution and is premature at this time. Conclusions concerning the effectiveness of calcium antagonists in suppressing atherosclerosis in humans must await the results of clinical trials with nifedipine and nicardipine (86).
Get full access to this article
View all access options for this article.